Atlas FDA

Barricaid Anular Closure Device

FDA premarket approval P160050/S002 · decided 2019-05-03

Approval details

PMA number
P160050
Supplement
S002
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Barricaid Anular Closure Device
Generic name
Reherniation reduction device
Applicant
Intrinsic Therapeutics
Date received
2019-03-11
Decision date
2019-05-03
Days to decision
53 days
Decision code
APPR
Product code
QES
Advisory committee
Orthopedic
Expedited review
No
Location
Woburn, MA
Statement
Approval for the addition of a manufacturing site for manual lapping and the addition of an automated lapping step.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.